F2G Ltd Completes $30 Million Financing Round to Fund Pre-clinical and Clinical Development of Novel Anti-fungal Compounds. Manchester, UK, Sept 5th 2012 - F2G Limited, an antifungal drug discovery ...

MANCHESTER, England, April 8, 2019 /PRNewswire/ -- F2G Ltd, the European biotech company developing novel therapies for life-threatening fungal infections, today announces the appointment of Dr.

(Reuters) - F2G said on Thursday it has raised $100 million from investors including AMR Action Fund, backed by large drugmakers such as Johnson & Johnson and Pfizer, to help it develop treatments for ...

Forbion, through its Forbion Growth Opportunities Fund II, co-led the $70 million round with Sofinnova Partners, alongside significant commitments from existing investors. Nanna Lüneborg, General ...